Proposed Information Collection Activity; Comment Request, 24493-24494 [2011-10458]
Download as PDF
<![CDATA[
mstockstill on DSKH9S0YB1PROD with NOTICES6
Federal Register / Vol. 76, No. 84 / Monday, May 2, 2011 / Notices
travel processing for federal employees,
Commissioned Corps and all CDCinvited guests; (2) provides direct
management and execution of the
administrative aspects of human
resources across NCIRD, including
training, and administration of policies
and guidelines developed by Office of
Human Resources, Atlanta Operations
Center, Department of Health and
Human Services, CDC Ethics Office,
Financial Management Office, Office of
Commissioned Corps Personnel, Center
for Global Health, Office of Personnel
Management, and Procurement and
Grants Office; (3) provides direct
management and execution of the
coordination of office facilities, and
supplies technical guidance and
expertise regarding occupancy and
facilities management to emergency
situations; (4) provides direct and daily
management and execution of the
distribution, accountability and
maintenance of CDC property and
equipment; (5) provides direct
management and execution of
procurement requisitions, and contracts
and performs administrative tasks
related to initiating, processing and
maintaining interagency agreements; (6)
provides direct management and
execution of the creation, organization,
access, maintenance and disposition of
CDC records, and of the establishment
of policies and procedures coordinating
a NCIRD response to Freedom of
Information Act requests; and (7)
provides direct management and
execution of the coordination of
logistics for Federal government
committee meetings and NCIRD
conferences.
Office of Science and Integrated
Programs (CVG17). (1) Links strategies
and priorities of the primarily
programmatic-focused NCIRD divisions
with those of primarily disease-based
divisions; (2) facilitates development
and ongoing implementation of
integrated infectious respiratory disease
(including influenza) surveillance,
research, and prevention and control
activities across the divisions, both
domestically and globally, including
supporting implementation of NCIRD’s
respiratory diseases strategic prevention
priorities; (3) interfaces with other CDC
CIOs working in the area of respiratory
diseases; (4) coordinates and facilitates
the center’s overall respiratory and
vaccine preventable disease scientific/
research agenda; (5) assumes
responsibility for the protection of
human research subjects, scientific
review, clearance of manuscripts and
other written materials; (6) provides
planning and coordination of overall
VerDate Mar<15>2010
17:48 Apr 29, 2011
Jkt 223001
surveillance strategies, preparedness,
response, and prevention effectiveness
related to a center-wide public health
scientific agenda and in quantifying
how programs and activities promote
cost-effective and high impact
prevention strategies with respect to
immunization and other vaccine
preventable disease programs; (7)
provides leadership (agency and centerwide) for vaccine preventable and
respiratory disease surveillance to
include guidance and coordination of
NCIRD surveillance activities and
systems, as well as leadership on issues
related to internal and external
integration of CDC surveillance
activities; (8) coordinates, facilitates and
integrates domestic and international
respiratory and vaccine preventable
disease surveillance activities through
existing methods while developing new
approaches, tools and analyses for these
activities; (9) fosters a multidisciplinary
approach to epidemiology, statistics,
informatics, laboratory methods and
evaluation; (10) facilitates cross-cutting
health services research and economic
analyses in the area of vaccine
preventable and respiratory diseases
and immunization programs and their
impact on and relationships to health
insurance reform; (11) provides
leadership in developing a center-wide
prevention effectiveness priority agenda
and facilitates the development and
ongoing implementation of integrated
modeling activities; (12) provides
leadership in facilitating the
development and implementation of the
center’s overarching influenza
surveillance, research, and prevention
strategy (pandemic and seasonal); and
(13) provides leadership across the
divisions with respect to linking
preparedness and response elements to
the overall influenza prevention and
control strategy, and interfaces with
other parts of CDC with respect to this
strategy.
Dated: April 19, 2011.
James D. Seligman,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–10503 Filed 4–29–11; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Statement of Organization, Functions,
and Delegations of Authority
Part C (Centers for Disease Control
and Prevention) of the Statement of
PO 00000
Frm 00037
Fmt 4703
Sfmt 4703
24493
Organization, Functions, and
Delegations of Authority of the
Department of Health and Human
Services (45 FR 67772–76, dated
October 14, 1980, and corrected at 45 FR
69296, October 20, 1980, as amended
most recently at 76 FR 15984–15985,
dated March 22, 2011) is amended to
reflect the reorganization of the
Laboratory Science, Policy, and Practice
Program Office, Office of Surveillance,
Epidemiology and Laboratory Services,
Centers for Disease Control and
Prevention.
Section C–B, Organization and
Functions, is hereby amended as
follows:
Delete item (1) of the functional
statement for Division of Laboratory
Policy and Practice (CPGB), Laboratory
Science, Policy, and Practice Program
Office (CPG), and insert the following:
(1) Ensures coordination and liaison
with the Office of Safety, Health and
Environment (OSHE) on laboratory
biosafety issues as part of the larger
Quality Management Systems for
laboratories.
Delete item (1) of the functional
statement for Technology Management
Branch (CPGBB) and insert the
following:
(1) Coordinates with OSHE and other
federal partners on cross-cutting safety
issues.
Delete items (2), (3) and (4) of the
functional statement for Technology
Management Branch (CPGBB) and
renumber the remaining items
accordingly.
Dated: April 15, 2011.
Carlton Duncan,
Acting Chief Operating Officer, Centers for
Disease Control and Prevention.
[FR Doc. 2011–10402 Filed 4–29–11; 8:45 am]
BILLING CODE 4160–18–M
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Administration for Children and
Families
Proposed Information Collection
Activity; Comment Request
Title: Low Income Home Energy
Assistance Program (LIHEAP) Carryover
and Reallotment Report.
OMB No.: 0970–0106.
Description: The LIHEAP statute and
regulations require LIHEAP grantees to
report certain information to HHS
concerning funds forwarded and funds
subject to reallotment. The 1994
reauthorization of the LIHEAP statute,
the Human Service Amendments of
1994 (Pub. L. 103–252), requires that the
E:\FR\FM\02MYN1.SGM
02MYN1
24494
Federal Register / Vol. 76, No. 84 / Monday, May 2, 2011 / Notices
Carryover and Reallotment Report for
one fiscal year be submitted to HHS by
the grantee before the allotment for the
next fiscal year may be awarded. The
Administration for Children and
Families is requesting no changes in the
collection of data with the Carryover
and Reallotment Report, a form for the
collection of data, and the Simplified
Instructions for Timely Obligations of
LIHEAP Funds and Reporting Funds for
Carryover and Reallotment. The form
clarifies the information being requested
and ensures the submission of all the
required information. The form
facilitates our response to numerous
queries each year concerning the
amounts of obligated funds. Use of the
form is voluntary. Grantees have the
option to use another format.
Respondents:
ANNUAL BURDEN ESTIMATES
Number of
respondents
Instrument
Carryover and Reallotment Report ..................................................................
mstockstill on DSKH9S0YB1PROD with NOTICES6
Estimated Total Annual Burden
Hours: 576.
In compliance with the requirements
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the
Administration for Children and
Families is soliciting public comment
on the specific aspects of the
information collection described above.
Copies of the proposed collection of
information can be obtained and
comments may be forwarded by writing
to the Administration for Children and
Families, Office of Administration,
Office of Information Services, 370
L’Enfant Promenade, SW., Washington,
DC 20447, Attn: ACF Reports Clearance
Officer. E-mail address:
infocollection@acf.hhs.gov. All requests
should be identified by the title of the
information collection.
The Department specifically requests
comments on: (a) Whether the proposed
collection of information is necessary
for the proper performance of the
functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
the quality, utility, and clarity of the
information to be collected; and (d)
ways to minimize the burden of the
collection of information on
respondents, including through the use
of automated collection techniques or
other forms of information technology.
Consideration will be given to
comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011–10458 Filed 4–29–11; 8:45 am]
BILLING CODE 4184–01–P
VerDate Mar<15>2010
17:48 Apr 29, 2011
Jkt 223001
192
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Food and Drug Administration
[Docket No. FDA–2011–D–0293]
Draft Guidance for Industry and FDA
Staff: Processing/Reprocessing
Medical Devices in Health Care
Settings: Validation Methods and
Labeling; Availability
AGENCY:
Food and Drug Administration,
HHS.
ACTION:
Notice.
The Food and Drug
Administration (FDA) is announcing the
availability of the draft guidance
document entitled ‘‘Draft Guidance for
Industry and FDA Staff: Processing/
Reprocessing Medical Devices in Health
Care Settings: Validation Methods and
Labeling.’’ The recommendations in this
guidance are intended to improve the
safety and effectiveness of devices with
processing or reprocessing labeling.
This draft guidance is not final; nor is
it in effect at this time.
DATES: Although you can comment on
any guidance at any time (see § 10.115
(21 CFR 10.115(g)(5))), to ensure that the
Agency considers your comment on this
draft guidance before it begins work on
the final version of the guidance, submit
electronic or written comments on the
draft guidance by August 1, 2011.
ADDRESSES: Submit written requests for
single copies of the draft guidance
document entitled ‘‘Draft Guidance for
Industry and FDA Staff: Processing/
Reprocessing Medical Devices in Health
Care Settings: Validation Methods and
Labeling’’ to the Division of Small
Manufacturers, International, and
Consumer Assistance, Center for
Devices and Radiological Health, Food
and Drug Administration, 10903 New
Hampshire Ave., Bldg. 66, rm. 4613,
Silver Spring, MD 20993–0002. Send a
fax request to 301–847–8149 to receive
a hard copy. Alternatively, you may
SUMMARY:
PO 00000
Frm 00038
Fmt 4703
Sfmt 4703
Number of
responses per
respondent
1
Average
burden hours
per response
3
Total burden
hours
576
submit written requests for single copies
of the draft guidance to the Office of
Communication, Outreach and
Development (HFM–40), Center for
Biologics Evaluation and Research, 1401
Rockville Pike, suite 200N, Rockville,
MD 20852. Send one self-addressed
adhesive label to the office that you are
ordering from to assist in processing
your requests. See the SUPPLEMENTARY
INFORMATION section for information on
electronic access to the guidance.
Submit electronic comments on the
draft guidance to https://
www.regulations.gov. Submit written
comments to the Division of Dockets
Management (HFA–305), Food and Drug
Administration, 5630 Fishers Lane, rm.
1061, Rockville, MD 20852. Identify
comments with the docket number
found in brackets in the heading of this
document.
FOR FURTHER INFORMATION CONTACT:
Steven Turtil, Center for Devices and
Radiological Health, Food and Drug
Administration, 10903 New
Hampshire Ave., Bldg. 66, rm. 1570,
Silver Spring, MD 20993–0002, 301–
796–6305; or
Stephen Ripley, Center for Biologics
Evaluation and Research (HFM–17),
Food and Drug Administration, 1401
Rockville Pike, suite 200N, Rockville,
MD 20852, 301–827–6210.
SUPPLEMENTARY INFORMATION:
I. Background
In recent years, there has been a
significant advance in knowledge and
technology involved in reprocessing
reusable medical devices. Additionally,
there has been an evolution towards
more complex reusable medical device
designs that are more difficult to clean
and disinfect or sterilize. The revision of
this guidance, originally published in
1996, reflects scientific advances in this
area. Under FDA labeling regulations
(part 801 (21 CFR part 801)), a device
must have adequate directions for use,
which include instructions on preparing
a device for use. Instructions on how to
E:\FR\FM\02MYN1.SGM
02MYN1
]]>Agencies
[Federal Register Volume 76, Number 84 (Monday, May 2, 2011)]
[Notices]
[Pages 24493-24494]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 2011-10458]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Administration for Children and Families
Proposed Information Collection Activity; Comment Request
Title: Low Income Home Energy Assistance Program (LIHEAP) Carryover
and Reallotment Report.
OMB No.: 0970-0106.
Description: The LIHEAP statute and regulations require LIHEAP
grantees to report certain information to HHS concerning funds
forwarded and funds subject to reallotment. The 1994 reauthorization of
the LIHEAP statute, the Human Service Amendments of 1994 (Pub. L. 103-
252), requires that the
[[Page 24494]]
Carryover and Reallotment Report for one fiscal year be submitted to
HHS by the grantee before the allotment for the next fiscal year may be
awarded. The Administration for Children and Families is requesting no
changes in the collection of data with the Carryover and Reallotment
Report, a form for the collection of data, and the Simplified
Instructions for Timely Obligations of LIHEAP Funds and Reporting Funds
for Carryover and Reallotment. The form clarifies the information being
requested and ensures the submission of all the required information.
The form facilitates our response to numerous queries each year
concerning the amounts of obligated funds. Use of the form is
voluntary. Grantees have the option to use another format.
Respondents:
Annual Burden Estimates
----------------------------------------------------------------------------------------------------------------
Number of Average
Instrument Number of responses per burden hours Total burden
respondents respondent per response hours
----------------------------------------------------------------------------------------------------------------
Carryover and Reallotment Report................ 192 1 3 576
----------------------------------------------------------------------------------------------------------------
Estimated Total Annual Burden Hours: 576.
In compliance with the requirements of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995, the Administration for Children and
Families is soliciting public comment on the specific aspects of the
information collection described above. Copies of the proposed
collection of information can be obtained and comments may be forwarded
by writing to the Administration for Children and Families, Office of
Administration, Office of Information Services, 370 L'Enfant Promenade,
SW., Washington, DC 20447, Attn: ACF Reports Clearance Officer. E-mail
address: infocollection@acf.hhs.gov. All requests should be identified
by the title of the information collection.
The Department specifically requests comments on: (a) Whether the
proposed collection of information is necessary for the proper
performance of the functions of the agency, including whether the
information shall have practical utility; (b) the accuracy of the
agency's estimate of the burden of the proposed collection of
information; (c) the quality, utility, and clarity of the information
to be collected; and (d) ways to minimize the burden of the collection
of information on respondents, including through the use of automated
collection techniques or other forms of information technology.
Consideration will be given to comments and suggestions submitted
within 60 days of this publication.
Robert Sargis,
Reports Clearance Officer.
[FR Doc. 2011-10458 Filed 4-29-11; 8:45 am]
BILLING CODE 4184-01-P
